Arthritis Radiotherapy
Which Arthritic Joints Have Been Studied With Low-Dose Radiation?
Evidence for low-dose radiotherapy varies across knee, hand, hip, shoulder, foot, and ankle osteoarthritis and should not be generalized.
Short answer: Low-dose radiotherapy has been reported for many painful joints, but the quality of evidence is uneven. Knee osteoarthritis has a positive recent sham-controlled trial. Hand osteoarthritis has negative sham-controlled evidence. For hip, shoulder, foot, and ankle disease, evidence is mostly observational or indirect.
Knee
Knee osteoarthritis is the most actively debated site. A 2025 multicenter trial found a higher four-month responder rate after 3 Gy than after sham treatment in selected grade 2 to 3 disease.
An earlier Dutch sham-controlled trial found no benefit using a different 6 Gy regimen and population. The disagreement means selection, dose, and longer follow-up matter.
Hand and fingers
The randomized hand trial found no significant improvement in pain, function, or measured inflammation compared with sham at three, six, or 12 months.
ArthroRad compared 3 Gy with 0.3 Gy rather than true sham and found improvement in both groups without a convincing dose-group difference. It cannot establish that radiation caused the benefit.
Hip
Hip osteoarthritis appears in retrospective series, but high-quality joint-specific randomized evidence is sparse. The hip is deeper than a hand or knee, changing planning and normal-tissue exposure.
Severe structural hip disease may be better addressed by arthroplasty when a person is medically eligible.
Shoulder
Published low-dose radiation experience often combines shoulder diagnoses such as osteoarthritis, tendon-related conditions, and calcific disease. Those are not interchangeable. Diagnosis-specific trials are needed before quoting a pooled response rate.
Foot and ankle
Reports include ankle arthritis, small-joint osteoarthritis, and painful heel conditions. Different anatomy and diagnoses make broad claims especially unreliable. Treatment fields near skin, bone, and nail beds also require site-specific counseling.
Why an evidence map matters
“Arthritis” is not one disease in one joint. A responsible consultation asks:
- Was this exact joint and diagnosis studied?
- Was the comparison a true sham?
- Did the study measure pain, function, or both?
- How long did follow-up last?
- Does structural severity match the patient?
Until stronger joint-specific trials are available, knee evidence should remain knee evidence—not a promise for every painful joint.
Questions patients often ask
Which joint has the best recent evidence?
The strongest positive recent sham-controlled signal is for selected mild-to-moderate knee osteoarthritis, with longer follow-up still important.
Can knee results predict benefit in the hand or hip?
No. Different joints have different anatomy and evidence, and the hand sham-controlled trials were negative.
Are shoulders and feet treated in published practice?
They appear in observational reports and European practice, but joint-specific randomized evidence is limited.
Sources and further reading
- Clinical Effectiveness of Low-Dose Radiation in Knee Osteoarthritis. ASTRO Annual Meeting (2025).
- Long-term efficacy in knee and hand osteoarthritis: sham-controlled trial follow-up. The Lancet Rheumatology (2020).
- ArthroRad trial: final results after 12-month follow-up. Strahlentherapie und Onkologie (2023).
- American Radium Society Appropriate Use Criteria for Low-Dose Radiotherapy. American Journal of Clinical Oncology (2026).
